Erythroderma due to ribostamycin
- 1 August 1989
- journal article
- research article
- Published by Wiley in Contact Dermatitis
- Vol. 21 (2) , 79-82
- https://doi.org/10.1111/j.1600-0536.1989.tb04701.x
Abstract
A 48‐year‐old man became erythrodermatous after intramuscular administration of ribostamycin, an aminoglycoside antibiotic in the same family as neomycin. Patch tests were positive to ribostamycin and neomycin, as well as to mercurials. There was no mercurial preservative in the injection solution. A lymphocyte transformation test was positive for ribostamycin and tobramycin, but not for gentamycin. Diagnostic and structure‐activity relationship aspects of the case are discussed.Keywords
This publication has 11 references indexed in Scilit:
- Gentamicin: Systemic exposure to a contact allergenJournal of the American Academy of Dermatology, 1988
- Patch test diagnosis in carbamazepine erythrodermaContact Dermatitis, 1986
- Patch test diagnosis of exfoliative dermatitis due to carbamazepineContact Dermatitis, 1985
- Cross‐sensitivity between aminoside antibioticsContact Dermatitis, 1980
- Tobramycin‐neomycin cross‐sensitivityContact Dermatitis, 1977
- Sensitization Potentials and Immunologic Specificities of NeomycinsJournal of Investigative Dermatology, 1975
- THE VALUE OF PATCH AND OTHER SKIN TESTS IN DRUG ERUPTIONSThe Lancet, 1974
- Cross-Sensitivity and Aminoglycoside AntibioticsArchives of Dermatology, 1973